Abstract
Apoptotic cell death plays a critical role in controlling cell number and tissue morphology in embryonic and adult organisms. Recently, there have been significant advances in the understanding of apoptosis at the cellular level. The cloning of diverse genes such as Fas and TNF α ligands/receptors, bcl-2, and ICE family members has lead to an increased knowledge of the signal transduction pathways used by cells to monitor and respond to their environment by inducing apoptosis. Components of the extracellular matrix play an important role in this process. Basement membrane and extracellular matrix contain information critical to the identity of the cell and the context in which it responds to external signals. Disruption of the matrix by the matrix-degrading metalloproteinases can therefore dramatically alter the response of cells to apoptotic signals. It is also interesting to consider that the proteolytic activity of metalloproteinases toward matrix components or other potential substrates provide alternative mechanisms by which degradative enzymes could actively influence apoptotic pathways. This review will discuss two systems in which metalloproteinases have been shown to be involved in apoptotic pathways and discuss potential mechanisms for this effect.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anichini, E., Fibbi, G., Pucci, M., Caldini, R., Chevanne, M., and Del Rosso, M. (1994). Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Experimental Cell Research 231, 438–448.
Baker, S. J., and Reddy, E. P. (1996). Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1–9.
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. A. (1993). Matrix Metalloproteinases: A Review. Critical Reviews in Oral Biology and Medicine 4, 197–250.
Blasi, F., Behrendt, N., Cubellis, M. V., Ellis, V., Lund, L. R., Masucci, M. T., Moller, L. B., Olson, D. P., Pedersen, N., Ploug, M., Ronne, E., and Dano, K. (1990). The urokinase receptor and regulation of cell surface plasminogen activation. Cell Differ.Dev. 32, 247–254.
Boudreau, N., Sympson, C. J., Werb, Z., and Bissel, M. J. (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891–893.
Boudreau, N., Werb, Z., and Bissell, M.J. (1996). Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA 93: 3509–3513.
Brooks, P.C., Montgomery, A.M.P., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G., and Cheresh D.A. (1996). Integrin αvβ3 antagonist promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157–1164.
Brown, P. D. (1995). Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Advances in Enzyme Regulation 35, 293–301.
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Woolley, K. (1994). Processing of tumour necrosis factor-a precursor by metalloproteinases. Nature 370, 555–557.
Hosaka, M., Nagahama, M., Kim, W. S., Watanabe, T., Hatsuzawa, K., Ikemizu, J., Murakami, K., and Nakayama, K. (1991). Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. Journal of Biological Chemistry 266, 12127–12130.
Hulboy, D.L., Rudolph, L.A., and Matrisian, L.M. (1996). Matrix metalloprotienases as mediators of reproductive function. Mol. Hum. Reprod. In Press.
Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fugii, Y., Sato, H., Seiki, M., and Okada, Y. (1996). Membrane-type matrix metalloproteinase lis a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56, 2707–2710.
Jenne, D. E., and Tschopp, J. (1992). Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci 17, 154–159.
Ju, S., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A. (1995). Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444–48.
Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K., and Yagita, H. (1995). Metalloproteinase-mediated release of human Fas ligand. Journal of Experimental Medicine 182, 1777–1783.
Lin, C. Q., and Bissell, M. J. (1993). Multi-faceted regulation of cell differentiation by extracellular matrix. Faseb J 7, 737–743.
Lund, L. R., Romer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Dano, K., and Werb, Z. (1996). Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and-dependent pathways. Development 122, 181–93.
Marcotte, P. A., Kozan, I. M., Dorwin, S. A., and Ryan, J. M. (1992). The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells. Journal of Biological Chemistry 267, 13803–13806.
Mason, M. D., Allman, R., and Quibel, M. (1996). Adhesion molecules in melanoma:more than just superglue? J Royal Acad Sci 89, 393–395.
McGeehan, G. M., Becherer, J. D., Bast, R. C., Jr., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B., Nichols, J., Pryzwansky, K. M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J., Ways, J. P. (1994). Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370, 558–561.
Meredith, J. E., Fazeli, B., and Schwartz, M. A. (1993). The extracellular matrix as a cell survival factor. Mol.Biol.Cell 4, 953–961.
Modlich, U., Kaup, F. J., and Augustin, H. G. (1996). Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74, 771–780.
Murphy, G., Crockett, M. I., Stephens, P. E., Smith, B. J., and Docherty, A. J. P. (1987). Stromelysin is an activator of procollagenase — a study with natural and recombinant enzymes. Biochem. J. 248, 265–268.
Pajouh, M., Nagle, R., Breathnach, R., Finch, J., Brawer, M., and Bowden, G. (1991). Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 117, 144–150.
Pei, D., and Weiss, S. J. (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244–247.
Powell, W., and Matrisian, L. (1995). Complex roles of matrix metalloproteinases in tumor progression. In Attempts to understand metastasis formation: metastasis related molecules, U. Gunthert and W. Birchmeier, eds. (Berlin: Springer-Verlag), pp. 1–22.
Powell, W. C., Dormann, F. E., Jr., Michen, J. M., Matrisian, L. M., Nagle, R. B., and Bowden, G. T. (1996). Matrilysin expression in the involuting rat ventral prostate. The Prostate, 159-168.
Puente, X. S., Pendas, A. M., Llano, E., Velasco, G., and Lopez-Otin, C. (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Research 56, 944–949.
Sanchez-Lopez, R., Alexander, C. M., Behrendtsen, O., Breathnach, R., and Werb, Z. (1993). Role of zinc-binding-and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins. J Biol Chem 268, 7238–7247.
Sanchez-Lopez, R., Nicholson, R., Gesnel, M. C., Matrisian, L. M., and Breathnach, R. (1988). Structure-function relationships in the collagenase family member transin. J Biol Chem 263, 11892–11899.
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61–64.
Sato, H., Kinoshita, T., Takino, T., Nakayama, K., and Seiki, M. (1996). Activation of a recombinant membrane type 1-metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Letters 393, 101–104.
Schulte-Hermann, R., Bursch, W., Kraupp-Grasl, B., Oberhammer, F., and Wagner, A. (1992). Programmed cell death and its protective role with particular reference to apoptosis. Toxicology Letters. 64–65 Spec No, 569–574.
Seiki, M. (1995). Membrane type-matrix metalloproteinase and tumor invasion. In Attempts to understand metastasis formation: metastasis related molecules, U. Gunthert and W. Birchmeier, eds. (Berlin: Springer-Verlag), pp. 23–32.
Sensibar, J. A., Sutkowski, D. M., Raffo, A., Buttyan, R., Griswold, M. D., Sylvester, S. R., Kozlowski, J. M., and Lee, C. (1995). Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res 55, 2431–2437.
Sympson, C. J., Alexander, C. M., Chin, J. R., Werb, Z., and Bissell, M. J. (1993). Transgenic expression of stromelysin from the WAP promoter alters branching morphogenesis during mammary gland development and results in precocious expression of milk genes. J. Cell Biol. 125:681–693.
Takino, T., Sato, H., Shinagawa, A., and Seiki, M. (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem 270, 23013–23020.
Will, H., and Hinzmann, B. (1995). cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231, 602–608.
Wilson, C., and Matrisian, L. (1996). Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. International Journal of Biochemistry and Cell Biology 28:123–136.
Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. M., and Matrisian, L. M. (1997). Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA. In Press.
Witty, J. P., Wright, J. H., and Matrisian, L. M. (1995a). Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-l in transgenic mice induces unscheduled alveolar development. Molecular Biology of the Cell 6, 1287–303.
Witty, J. P., Lempka, T., Coffey, R. J., Jr., and Matrisian, L. M. (1995b). Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-l transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Research 55, 1401–1406.
Woessner, J., and Taplin, C. (1988). Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 263, 16918–16925.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Powell, W.C., Matrisian, L.M. (1997). Mechanisms by Which Matrix Metalloproteinases May Influence Apoptosis. In: Shi, YB., Shi, Y., Xu, Y., Scott, D.W. (eds) Programmed Cell Death. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0072-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0072-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0074-6
Online ISBN: 978-1-4899-0072-2
eBook Packages: Springer Book Archive